References
- Freitas CH, Muller H. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN TM) dispersions. Int J Pharm 1998;168(2):221–229.
- Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 1997;157:171–179.
- Wang D, Zhao C, Zhang R, Li X, Cui F. Preparation and characterization of total flavones of hippophae rhamnoides (TFH) solid lipid nanoparticles by heating-ultrasonic dispersion and lyophilization. Asian J Pharm Sci 2006;1(3–4):205–212.
- Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F, Azarmi S, Kobarfard F. Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J Liposome Res 2010;20(2):97–104.
- Bartal C, Danon A, Schlaeffer F, Reisenberg K, Alkan M, Smoliakov R, Sidi A, Almog Y. Pharmacokinetic dosing of aminoglycosides: A controlled trial. Am J Med 2003;114(3):194–198.
- Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticle loaded with doxorubicin. Eur J Pharm Sci 2009;37:508–513.
- Rodriguez A, Solinis MA, Gascon AR, Pedraz JL. Short and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 2009;71:181–189.
- Ohshima H, Miyagishima A, Kurita T, Makino Y, Lwao Y, Sonobe T, Itai S. Freeze-dried nifedipine lipid nanoparticles with long-term nano dispersion stability after reconstitution. Int J Pharm 2009;377:180–184.
- Zimmermann E, Muller RH, Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharmaceut 2000;196:211–213.
- Yang S, Zhu J., Preparation, and characterization of camptothecin solid lipid nanoparticles. Drug, Dev Ind Pharm 2002;28(3):265–274.
- Lim S-J, Kim C-K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243:135–146.
- Vighi E, Ruozi B, Montanari M, Battini R, Leo E. Re-dispersible cationic solid lipid nanoparticles freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm 2007;67:320–328.
- Myers RH, Montgomery D. Response surface methodology: Process and product optimization using designed experiments. 2nd ed. New York: Wiley; 2002:1–17.
- Hu FQ, Hong Y, Yang H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004;273:29–35.
- Jeong Y, Shim Y, Kim C, Lim G, Choi C, Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-Lactide-co-glycolide). J Microencapsul 2005;22(6):593–601.
- Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles for controlled drug delivery-drug release and drug mechanism. Eur J Pharm Biopharm 1998;45(2):149–155.
- Doijad R., Manvi F, Godhwani D, Joseph R, Deshmukh N. Formulation and targeting efficiency of cisplatin engineered solid lipid nanoparticles. Indian J Pharm Sci 2008:70(2):203–207.
- Nounou MM, Khordagui L, Khallafallah N, Khalil S. Influence of different sugar cryoprotectants on the stability and physicochemical characteristics of freeze dried 5-Fluorouracil plurilamellar vesicles. Daru 2005;13(4):133–142.
- Hsu CH, Mumper RJ, Cui Zh Jay, M. Preparation and characterization of novel Co-Q10 nanoparticles engineered from microemulsion precursors. AAPS PharmSciTech 2003;4(3): Article 32.
- Varshosaz J, Talari R, Mostafavi SA, Nokhodchi A. Dissolution enhancement of gliclazide using in situ micronization by solvent change method. Powder Technol 2008;187(3):222–230.